Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 26 years of covering Asia Pacific equities, the past 20 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Austal (ASB AU): Hanwha Cleared To Lift Stake To 19.9%

Austal (ASB AU): A Hanwha Bid Is Back In Play

Austal (ASB AU): Hanwha's Offer For U.S. Unit After Contractual Relief Goes Astray

Quiddity Advisors

Event-Driven

<ul>
<li>When <a href="https://www.smartkarma.com/entities/austal-ltd" target="_blank" data-smartkarma-citation="entities:14420:1" rel="noopener">Austal Ltd (ASB AU)</a> confirmed preliminary discussion with Wildcat Infrastructure, I mused this may be a ruse to extract more gruel from Hanwha. I was clearly too cynical.</li>
<li>A short while ago, Austal <a href="https://announcements.asx.com.au/asxpdf/20260909/pdf/073x3xcqlxvlpl.pdf" target="_blank" rel="noopener">confirmed</a> Wildcat has pitched a "non-binding indication of interest" for Austal's US ops at an EV of US$1.25-1.35bn, a ~12.5% premium to Hanwha's indicative terms.</li>
<li>Wildcat is requesting for four weeks of due diligence. Austal is mulling its options. Hanwha has the clout to match and/or exceed Wildcat's terms.</li>
</ul>


When Austal Ltd (ASB AU) confirmed preliminary discussion with Wildcat Infrastructure, I mused this may be a ruse to extract more gruel from Hanwha. I was clearly too cynical.
A short while ago, Austal confirmed Wildcat has pitched a "non-binding indication of interest" for Austal's US ops at an EV of US$1.25-1.35bn, a ~12.5% premium to Hanwha's indicative terms.
Wildcat is requesting for four weeks of due diligence. Austal is mulling its options. Hanwha has the clout to match and/or exceed Wildcat's terms.


Austal (ASB AU): Not A Ruse Afterall As Wildcat Tables Indicative Offer For U.S. Ops